Knowledge of current HCV screening guidelines is critical, especially now that the recommendations have changed to address the higher incidence of HCV infection among injection drug users as a result of the opioid epidemic.

Practical overview of current trends in treatment for chronic HF. Improve therapeutic decision making for patients with chronic HF. Reducing rehospitalizations and improving patient outcomes.

This webcast on bleeding risk summarizes current guidelines, mechanisms of action, safety, and efficacy of reversal agents for anti coagulation and utilizes these guidelines and evidence-based recommendations for the use of reversal agents to establish best practices to access anticoagulant antidotes in the critical care settings.

Etiology and pathophysiology of cardiometabolic syndrome and the development of cardiovascular disease in people with type 2 diabetes

This online activity will provide patient-centered, video-based education that explores care challenges that exist in the period of transition from pediatric care to adult care.

Duchenne Muscular Dystrophy – An Expanding Lifespan This two session activity summarizes the differential diagnosis of DMD and applicable diagnostic approaches as well as assess the therapeutic potential of available and emerging treatment options for the management of DMD

Identify those patient populations most likely to present with or develop hyperkalemia, and utilize the appropriate conventional and/or novel agents to correct subacute hyperkalemia.

At the conclusion of this activity, participants should be able to describe the rationale for evaluating the cardiovascular impact of antidiabetes medications, and key data from recent cardiovascular outcomes trials of antidiabetes medications.